HealthVerity Patient Confidence Index (HVPCI) signals dramatic changes in patient behavior due to COVID-19
April 30, 2020 - Philadelphia, PA -HealthVerity announced the biweekly update to its HealthVerity...
Understanding re-identification risk in PPRL: key takeaways from our expert webinar
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL). While PPRL remains essential for de-identified data exchange, the study presented during our recent webinar shows that certain token-based approaches...
HVPCI sees its highest score as patients continue to seek care
July 9, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
Building Smarter Value-Based Agreements with Real-World Data
Value-based agreements unite pharma companies and payers with a mutually beneficial payment model,...
HealthVerity pulse: Q2 in review
Throughout the past quarter, we’ve announced major collaborations, built on existing partnerships...
HealthVerity Patient Confidence Index (HVPCI) upgraded to Critical as physician visits rise sharply
June 25, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
HealthVerity Patient Confidence Index (HVPCI) downgraded to Severe as telehealth visits diminish
June 11, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
HealthVerity Patient Confidence Index (HVPCI) advances to Critical even as telehealth visits plateau
May 28, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
HVPCI reinforces the severe state of healthcare in America
May 14, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
Real-time data interoperability in the COVID-19 era
The COVID-19 outbreak has created an unprecedented need for real-time data. As the global pandemic...
Making decisions with real-world evidence and COVID-19
The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and...